| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |